Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
332 studies found for:    "Pancreatitis"
Show Display Options
RSS Create an RSS feed from your search for:
"Pancreatitis"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Terminated DP-b99 in the Treatment of Acute High-risk Pancreatitis
Condition: Pancreatitis
Interventions: Drug: DP-b99;   Drug: Placebo
2 Terminated Diclofenac for the Prevention of Post-ERCP Pancreatitis in Higher Risk Patients
Condition: Pancreatitis
Interventions: Drug: diclofenac;   Drug: placebo
3 Completed
Has Results
A Trial of Aprepitant For Prevention of Post-Endoscopic Retrograde Cholangiopancreatography (ERCP) Pancreatitis
Condition: Pancreatitis
Interventions: Drug: aprepitant;   Drug: Placebo
4 Recruiting Early Enteral Nutrition in Severe Acute Pancreatitis
Condition: Pancreatitis
Interventions: Other: early enteral nutrition;   Other: modified early enteral nutrition
5 Recruiting Fluid Resuscitation Goal in Early Stage of Severe Acute Pancreatitis
Condition: Pancreatitis
Interventions: Other: Goal A;   Other: Goal B
6 Suspended Ulinastatin in Severe Acute Pancreatitis
Condition: Pancreatitis
Interventions: Drug: ulinastatin;   Drug: placebo
7 Recruiting Trial of Index Cholecystectomy Versus Scheduled Cholecystectomy in Biliary Pancreatitis
Condition: Pancreatitis
Interventions: Procedure: Index cholecystectomy;   Procedure: Scheduled cholecystectomy
8 Completed Comparing the Outcome in Patients of Acute Pancreatitis, With and Without Prophylactic Antibiotics
Condition: Acute Pancreatitis
Intervention: Drug: Meropenem
9 Completed
Has Results
Secretin Infusion for Pain Due to Chronic Pancreatitis
Condition: Chronic Pancreatitis
Intervention: Drug: Human Secretin
10 Recruiting Study to Assess the Prognostic Value of the Antithrombin III in the Acute Pancreatitis (AT-PROPANC)
Condition: Acute Pancreatitis
Intervention:
11 Recruiting Fluid Resuscitation in Acute Pancreatitis
Condition: Pancreatitis
Intervention: Drug: Ringer lactate
12 Terminated Safety and Efficacy Study of Thalomid in Patients With Chronic Pancreatitis
Condition: Chronic Pancreatitis
Intervention: Drug: Thalidomide
13 Unknown  EUROPAC-2 - Pain Treatment of Hereditary and Idiopathic Pancreatitis
Condition: Pancreatitis
Interventions: Drug: Magnesium (15 mmol/d);   Drug: ANTOX (vers.) 1.2 (300 µg organic selenium, 54000 IU beta carotene, 750 mg vitamin C, 540 IU vitamin E, 2700 mg methionine)
14 Terminated Endoscopic Ultrasound (EUS) Features of Chronic Pancreatitis
Condition: Chronic Pancreatitis
Intervention: Other: chronic pancreatitis
15 Completed Randomized Trial of Aggressive Fluid Hydration to Prevent Post ERCP Pancreatitis
Condition: Pancreatitis
Interventions: Other: Aggressive Intravenous Hydration Group;   Other: Standard Fluids Arm
16 Completed Correlation of Chronic Pancreatitis Pathology Features With Endoscopic Ultrasound (EUS) Criteria
Condition: Chronic Pancreatitis
Intervention:
17 Active, not recruiting Abstats: Computer-aided, Non-invasive, Acoustic Gastrointestinal Surveillance (AGIS) in Acute Pancreatitis
Condition: Pancreatitis
Intervention: Device: Abstats sensor
18 Completed Home Treatment of Acute Pancreatitis
Condition: Acute Pancreatitis
Intervention:
19 Completed A Pilot Study of Use of Calcium Channel Blocker to Decrease Inflammation and Pain in Hereditary Pancreatitis
Condition: Pancreatitis
Intervention: Drug: amlodipine (drug)
20 Active, not recruiting Management of Pancreatitis: the Role of Supportive and Drainage Treatment
Condition: Pancreatitis
Interventions: Procedure: Percutaneous catheter drainage;   Procedure: Abdominal paracentesis evacuation

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.